The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Proton therapy of cancer: Potential clinical advantages and cost-effectiveness
Open accessAbstract
Proton therapy may offer potential clinical advantages compared with conventional radiation therapy for many cancer patients. Due to the large investment costs for building a proton therapy facility, however, the treatment cost with proton radiation is higher than with conventional radiation. It is therefore important to evaluate whether the medical benefits of proton therapy are large enough to motivate the higher costs. We assessed the cost-effectiveness of proton therapy in the treatment of four different cancers: left-sided breast cancer, prostate cancer, head and neck cancer, and childhood medulloblastoma. A Markov cohort simulation model was created for each cancer type and used to simulate the life of patients treated with radiation. Cost and quality adjusted life years (QALYs) were used as primary outcome measures. The results indicated that proton therapy was cost-effective if appropriate risk groups were chosen. The average cost per QALY gained for the four types of cancer assessed was about pounds 10,130. If the value of a QALY was set to pounds 55,000, the total yearly net benefit of treating 925 cancer patients with the four types of cancer was about pounds 20.8 million. Investment in a proton facility may thus be cost-effective. The results must be interpreted with caution, since there is a lack of data, and consequently large uncertainties in the assumptions used.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Methods for the Economic Evaluation of Health Care Programmes
Drummond, M. E., Sculpher, M. J., Torrance, G. W., O’Brien, B. J., & Stoddart, G. L. (2005) · doi:10.1093/oso/9780198529446.001.0001 · Cited by 13,648
Darby, S., McGale, P., Peto, R., Granath, F., Hall, P., & Ekbom, A. (2003) · BMJ · doi:10.1136/bmj.326.7383.256 · Cited by 235
Patient and Community Preferences for Outcomes in Prostate Cancer: Implications for Clinical Policy
Krahn, M., Ritvo, P., Irvine, J., Tomlinson, G., Bremner, K. E., Bezjak, A., Trachtenberg, J., & Naglie, G. (2003) · Medical Care · doi:10.1097/00005650-200301000-00017 · Cited by 119
Cited by
Chordoma: current concepts, management, and future directions
Walcott, B. P., Nahed, B. V., Mohyeldin, A., Coumans, J.-V., Kahle, K. T., & Ferreira, M. J. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70337-0 · Cited by 769
Contemporary radiotherapy: present and future
Chandra, R. A., Keane, F. K., Voncken, F. E. M., & Thomas, C. R. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00233-6 · Cited by 380
Metadata
- Authors
- Lundkvist, J., Ekman, M., Ericsson, S. R., Jönsson, B., & Glimelius, B.
- Venue
- Acta Oncologica
- Published
- 2005-01
- Volume
- 44
- Issue
- 8
- Pages
- 850-861
- ISSN
- 0284-186X (ISSN-L)
- 1651-226X
- OpenAlex
- W1986376168
- Cited by
- 172
- References
- 3
- FWCI
- 5.92
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Proton therapy of cancer: Potential clinical advantages and cost-effectiveness. https://app.cochat.ai/papers/10.1080/02841860500341157
- The paper
- Lundkvist, J., Ekman, M., Ericsson, S. R., Jönsson, B., & Glimelius, B. (2005). Proton therapy of cancer: Potential clinical advantages and cost-effectiveness. Acta Oncologica. https://doi.org/10.1080/02841860500341157
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.